HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1

CUSIP: 44052TAB7

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class
Debt / NOTE 2.500% 3/1
Market price (% of par)
193.44%
Total 13F principal
$181,474,500
Principal change
-$197,650,700
Total reported market value
$352,716,000
Number of holders
20
Value change
-$251,221,368
Number of buys
8
Number of sells
25

Quarterly Holders Quick Answers

What is CUSIP 44052TAB7?
CUSIP 44052TAB7 identifies 44052TAB7 - HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 as of Q2 2020

As of 30 Jun 2020, HORIZON PHARMA INVT LTD - NOTE 2.500% 3/1 was held by 20 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $181,474,500 in principal (par value) of the bond. The largest 10 bondholders included DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), FARALLON CAPITAL MANAGEMENT LLC, M&G INVESTMENT MANAGEMENT LTD, AMUNDI PIONEER ASSET MANAGEMENT INC, SSI INVESTMENT MANAGEMENT LLC, JPMORGAN CHASE & CO, BlackRock Inc., STATE STREET CORP, MORGAN STANLEY, and Kohlberg Kravis Roberts & Co. L.P.. This page lists 20 institutional bondholders reporting positions for the Q2 2020 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.